Middle East News Dispatch
SEE OTHER BRANDS

The most trusted news from the Middle East

Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on August 13, 2025

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced, through its pharmaceutical division, the closing of its previously announced investment in LayerBio, Inc., a privately held Boston-based biotechnology …

Latin Metals Expands Para Copper Project, Peru

Latin Metals Expands Para Copper Project, Peru

VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") - (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce that its 100% owned subsidiary Zafiro Mining S.A.C. has acquired additional mineral …

Clene to Present at the Emerging Growth Conference

Clene to Present at the Emerging Growth Conference

SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment …

Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme

Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme

First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …

Infinidat Wins 2025 FMS Award for Most Innovative AI Application with RAG Reference Architecture on the InfiniBox® G4 Platform

Infinidat Wins 2025 FMS Award for Most Innovative AI Application with RAG Reference Architecture on the InfiniBox® G4 Platform

WALTHAM, Mass., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that Infinidat’s Retrieval-Augmented Generation (RAG) reference architecture, operating on the new-generation InfiniBox® G4 …

Integral Metals Announces Private Placement Offering

Integral Metals Announces Private Placement Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that it …

Emerita Resources Announces C$15 Million Private Placement

Emerita Resources Announces C$15 Million Private Placement

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: …

Nexxen Reports Second Quarter 2025 Financial Results

Nexxen Reports Second Quarter 2025 Financial Results

Generated record Q2 Contribution ex-TAC, programmatic revenue and CTV revenue Increased Adjusted EBITDA Margin to 34% of Contribution ex-TAC from 32% in Q2 2024 Renewed and expanded strategic partnership with VIDAA in Q3 2025 through at least the end of …

PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results

PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Positive Phase 3 SHIELD II Trial Results - D-PLEX₁₀₀ successfully met its primary efficacy endpoint and demonstrated 58% reduction in SSI NDA submission expected in Q1 2026 Unveiled a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the …

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

Achieved record quarterly revenue of $12.6 million in Q2 2025, an increase of 26% compared to Q2 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.5 million, Raised full-year 2025 Revenue and EBITDA guidance Remaining performance …

Amerigo’s MVC Resumes Fresh Tailings Processing

Amerigo’s MVC Resumes Fresh Tailings Processing

El Teniente restarts operations and is sending fresh tailings to MVC Historic tailings processing remains ongoing Timing of normalized operations at El Teniente to determine impact on MVC guidance VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) …

Nasus Pharma Announces Pricing of $10 Million Initial Public Offering

Nasus Pharma Announces Pricing of $10 Million Initial Public Offering

TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …

LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency

LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency

PASADENA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that its Board of Directors has approved a strategic …

Nayax Reports Second Quarter 2025 Results 

Nayax Reports Second Quarter 2025 Results 

Revenue of $95.6 million, recurring revenue growth of 32% Gross margin improves to 48.3% Net income of $11.7 million with Adjusted EBITDA of $12.6 million(1) Total transaction value up 34%, Customer base increases 24% Company reaffirms full year 2025 …

On World Organ Donation Day KFSHRC Announces 10 Kidney Exchange Transplants Completed in 48 Hours

On World Organ Donation Day KFSHRC Announces 10 Kidney Exchange Transplants Completed in 48 Hours

RIYADH, Saudi Arabia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) successfully performed 10 kidney exchange transplants over two consecutive days, setting a global record for the highest number of such …

Gauzy Ltd. Announces Second Quarter 2025 Results

Gauzy Ltd. Announces Second Quarter 2025 Results

Record Backlog Purchase Orders of $42.9 Million at Quarter End Highly Anticipated New Product Lines Announced; Includes Commercial Aircraft Cabin Shading, ADAS Smart Vision for Buses, and Pre-Fabricated Stacks for Smart Glass New Strategic Customers …

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results

More than 45 patients enrolled in Emi-Le Phase 1 dose expansion cohorts in post-topoisomerase-1 inhibitor ADC (post-topo-1) triple-negative breast cancer (TNBC) Plan to report initial clinical data from Emi-Le expansion cohorts in second half of 2025 …

Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance

Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance

First Half 2025 Total Revenues were $88.8 Million, up 11% Year-over-Year; Revenues for 2025 Second Quarter were $44.8 Million, up 5% Year-over-Year First Half 2025 Adjusted EBITDA of $22.5 Million, up 35% Year-over-Year and Representing 25% Margin of …

PDS Biotech Reports Second Quarter 2025 Financial Results and Provides Clinical Programs Update

PDS Biotech Reports Second Quarter 2025 Financial Results and Provides Clinical Programs Update

Multiple Abstracts Presented at the 2025 American Society of Clinical Oncology Annual Meeting Conference call and webcast today at 8:00 a.m. Eastern Time PRINCETON, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS …

Oroco Receives Positive Resolution from Mexico’s Environment Ministry

Oroco Receives Positive Resolution from Mexico’s Environment Ministry

VANCOUVER, Canada, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce that it has received a positive resolution from the Mexican Federal Secretaría del Medio Ambiente y …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions